Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 23.09

+1.2%

10:12 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Irish who wrote (3338)	6/22/1998 7:05:00 PM
From: Steve	Read Replies (1) of 5736

Maybe this explains it better: If you suspect an infants bilirubin is high and you use CCSI's device and it confirms that the bilirubin is high then you must then do a blood test to determine which fraction is elevated. Here are the two scenarios, which one do you think insurance companies will pay for? Scenario 1: Baby looks jaundice. Hospital uses CCSI's device to confirm this. (Cost ~$30.00). Device says TOTAL BILIRUBIN is high. Now you must do a blood test (Cost ~$20.00) This tells you which fraction is high and the total bilirubin level and you go from there. TOTAL COST to patient ~$50.00 Scenario 2: Baby looks jaundice. Hospital does blood test which tells the doctor fraction is high and the total bilirubin level and you go from there. TOTAL COST to patient ~$20.00 With every single hospital in the country cutting costs any way they can, which scenario would you choose.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next